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Pulmonary fungal infections often occur in patients immunocom-
promised by various conditions such as cancer and neutropenia
(Biswas et al., 2010). Pseudozyma aphidis is an unusual pathogen
commonly isolated from plants (Sugita et al., 2003). This is a
ustilaginomycetes anamorphic yeast. There are so far only 1 case
report of human infection by P. aphidis in blood and central venous
catheter (Lin et al., 2008). Here, we reported a ﬁrst case of pulmonary
infection due to P. aphidis.2. Case report
A 17-year-old man treated with chemotherapeutics for Burkitt
lymphoma was hospitalized in a public pediatric oncology center in
Recife, Brazil. The patient used in chemotherapy treatment cyclophos-
phamide, vincristine, methotrexate, ifosfamide, carboplatin, etoposide,
doxorubicin, and predinisone. After the initiation of chemotherapy, the
patient presented a persistent severe febrile neutropenia (neutrophil
counts b100/mm3). Broad-spectrum antibiotics and antifungal prophy-
laxis with ﬂuconazole (Pﬁzer, São Paulo, Brazil) (400 mg/day) for 15
days and, afterwards, with caspofungin (Merck Research Laboratories,Whitehouse Station, NJ, USA) (0.5 mg/day) for 23 days were stated.
After 38 days of hospitalization and chemotherapy treatment, the
neutropenic patient developed fever as high as 39 °C, cough, bloody
sputum, and a chest X-ray–detected bilateral inﬁltrates and pleural
effusion. The hemogram counts were 80/mm3 for neutrophils and
29,000/mm3 for platelets. Caspofungin therapy was suspended. Blood
cultures were collected for the bacteriologic diagnosis; however, all
were negatives. After the symptoms worsened, the patient was
admitted to the intensive care unit of the same hospital with
respiratory insufﬁciency due to a probable pulmonary infection.
Venous blood samples were collected aseptically from the central
and peripheral veins by venipuncture, and 3 samples of pleural ﬂuid
were aseptically collected via thoracentesis. The samples were
processed immediately after collection by standard methods of
mycologic diagnosis (direct examination and culture).
Microbiological identiﬁcation was achieved using traditional
taxonomy according to the criteria described by Barnett et al.
(2000) and Boekhout and Fell (1998), through the VITEK 2 system
(BioMerieux, Brazil) and by sequencing fragments of the internal
transcribed spacer region of the rDNA using the primers ITS-1 and ITS-
4 (Gonçalves et al., 2012).
Antifungal susceptibility testing was performed in accordance with
the Clinical and Laboratory Standards Institute (CLSI) M27-A3 docu-
ment (CLSI, 2008). The antifungal drugs liposomal amphotericin B
(AMB; United Medical, São Paulo, Brazil), anidulafungin (ANI; Pﬁzer),
caspofungin (CAS; CaspofunginMSD,Merck),ﬂuconazole (FLZ; (Pﬁzer),
itraconazole (ITZ; Janssen, Titusville, NJ, USA), and voriconazole (VRZ;
Fig. 1. Microscopic examination of culture on Sabouraud dextrose agar media after 7
days of incubation at 37 °C showing elongated spindle-shaped blastoconidia consistent
with Pseudozyma species.
105A.M.R. de Carvalho Parahym et al. / Diagnostic Microbiology and Infectious Disease 75 (2013) 104–106Pﬁzer) were tested. The quality control was performed by testing CLSI-
recommended strain C. parapsilosis ATCC 22019.
Blood cultures were negative. The direct examinations of the
pleural ﬂuid showed various hyaline blastoconidia, and the cultures
after 7 days of growth at 30 °C and 37 °C on Sabouraud dextrose agar
(Difco; BD Diagnostics, Franklin Lakes, NJ, USA) media, showed moist
yeast colonies, brownish yellow and wrinkled in all samples.
Microscopic examination of the culture showed elongated spindle-
shaped blastoconidia (see Fig. 1). The organism was positive for urea
hydrolysis and for assimilation of galactose, D-xylose, D-arabinose,
sucrose, lactose, Meα-D-glucoside, maltose, rafﬁnose, soluble starch,
trehalose, and nitrate, and was negative for assimilation of cellobiose
and inulin. According to these morphologic and biochemical charac-
teristics, this isolate was identiﬁed with P. aphidis. The VITEK 2 system
showed the same assimilation proﬁle described by Barnett et al.
(2000) for P. aphidis.
A BLAST search produced a 100% match between the P. aphidis ITS
rDNA sequences in the GenBank database. The DNA sequence was
submitted to GenBank with the accession number of JQ743064. The
isolate was submitted to a stock collection of the Department of
Mycology, Federal University of Pernambuco, Brazil, with record
number 6351.
The antifungal susceptibility test showedMIC values of 0.25 μg/mL
for AMB, 4.0 μg/mL for ANI, 4.0 μg/mL for CAS, 4.0 μg/mL for FLZ, 0.25
μg/mL for ITZ, and 0.03 μg/mL for VRZ. Thus based on MIC values
presented in the document M27-A3 for other yeasts, the isolate was
susceptible to AMB, FLZ, ITZ, and VRZ, and resistant to ANI and CAS.
Accordingly, the patient was treated with a 10-day course of
intravenous amphotericin B lipid complex (Bagó, Brazil) (5 mg/kg perTable 1
Cases of human infection due to Pseudozyma species described in the literature.
Author Isolate Underlying disease Age Sympto
Sugita et al.
(2003)
Pseudozyma parantarctica
P. thailandica
Leptospirosis and
aseptic meningitis
Acute asthmatic attack
and respiratory failure
21 years old
52 years old
Not rep
Lin et al.
(2008)
P. aphidis Short gut syndrome 7 years old Intermit
malaise
Hwang et al.
(2010)
Pseudozyma sp. Astrocytoma 78 years old Weakne
mass in
and feveday) and, afterwards, with a 15-day course of oral voriconazole
(Pﬁzer) (400mg/day). This antifungal therapy resulted in a successful
clinical improvement as veriﬁed by chest X-ray and the absence of
clinical manifestations.
3. Discussion
The percentage of patients who develop invasive fungal in-
fections has increased dramatically in recent decades. Most of these
infections occur in patients with hematologic malignancies (Monta-
gna et al., 2012). This increase is attributed to host defense
impairment due to intensive cytotoxic chemotherapies, hematopoi-
etic stem cell transplantation, ablative radiation therapy, and use of
corticosteroids, cyclosporine, and new immunosuppressive agents
(Muhlemann et al., 2005).
During the last 20 years, other opportunistic fungal pathogens,
such as Fusarium spp. and Zygomycetes, have also emerged
(Kontoyiannis et al., 2005), whereas infections caused by other
fungi are still rare (Girmenia et al., 2005).
P. aphidis is an anamorphic yeast related to the smut fungi in the
genus Ustilago. This yeast is mainly isolated with a phytopathogen
(Sugita et al., 2003). However, invasive human infections due to this
species are rarely reported and little is known about its pathogenicity
(Lin et al., 2008).
Sugita et al. (2003) reported the isolation of P. aphidis from a blood
culture taken from a Thai patient, and Lin et al. (2008) described a
case of central venous catheter (CVC) infection in a child with short
gut syndrome. Still, a brain abscess associated with Pseudozyma
species in a patient with astrocytoma was reported by Hwang et al.
(2010). Infections due to Ustilago species have been reported in
patients with chronic skin rash (Teo and Tay, 2006), hypersensitivity
pneumonitis (Yoshida et al., 1996), and CVC infection (Patel et al.,
1995). In the case reported by Yoshida et al. (1996), the patient was
infected by U. esculenta and showed the same clinical aspects as in our
patient. The analysis of the cases of human infection due to
Pseudozyma species described in the literature is shown in Table 1.
Due to the rarity of Pseudozyma species infection in humans, no
MIC breakpoints exist for this organism; limited susceptibility data
suggested that some Pseudozyma species are susceptible to AMB
(Sugita et al., 2003). In the case described for Lin et al. (2008), the P.
aphidis isolate was susceptible to FLZ. In this article, the isolate was
susceptible to AMB, FLZ, ITZ, and VRZ, but resistant to ANI and CAS.
The results suggest a clinical and laboratorial resistance for echino-
candin due to the occurrence of P. aphidis infection after treatment
with CAS and antifungal susceptibility in vitro test results. Others
studies reported C. guilliermondii and C. parapsilosis with decreased
susceptibility to echinocandins (Munro, 2010).
To the best of our knowledge, our patient is the ﬁrst report of
pulmonary infection due to P. aphidis. We believe that the patient was
infected through inhalation of conidia in the hospital environment.
Due to immunosuppression caused by chemotherapy, reducing thems Clinical sample Treatment Outcome
orted Blood obtained from 3
patients
Not
reported
Not reported
tent fever, chills,
, and fatigue
Blood
Central venous catheter
Fluconazole
(dose not mentioned),
itraconazole
(5 mg/kg per day)
Cure
ss in right leg,
cerebral lobe,
r
Biopsy examination
from cerebral abscess
Antifungal therapy not
initiated
Death due to
multi-organ
failure
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respiratory tract and subsequent infection.
In summary, pulmonary infection due to P. aphidis can occur in
patients with Burkitt lymphoma and the treatment of this mycosis
with amphotericin B associated with voriconazole proved to be
effective. Our case indicates that physicians caring for cancer patients
need to be aware of these unusual yeasts as a potential source of
respiratory infection.
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